Metoprolol tartrate: Clinical Trials

19 trials of Metoprolol tartrate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 2 enrolling by invitation, 2 unknown, 1 not yet recruiting. 10 Phase 4, 3 Phase 1, 3 Phase 3, 2 Not applicable, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 410Completed 5, Unknown 2, Enrolling by invitation 1, Not yet recruiting 1, Recruiting 1
Phase 13Completed 2, Withdrawn 1
Phase 33Completed 2, Enrolling by invitation 1
Not applicable2Completed 2
Phase 22Enrolling by invitation 1, Withdrawn 1
Early Phase 11Completed 1

Follow Metoprolol tartrate: new trials by email Literature Review of Metoprolol tartrate trials Research Report on Metoprolol tartrate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparing Two Heart Medicines for Fast, Irregular Heartbeat (Atrial Fibrillation)
Verapamil Hydrochloride, Metoprolol tartrate - Atrial Fibrillation (AF), Atrial Fibrillation With Rapid Ventricular Response
Phase 4Not yet recruitingMuhammad Ali Javed1202027-01-012026-08-03
Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF)
Placebo (matching), Beta-blockers - Heart Failure, HFpEF
Phase 4Enrolling by invitationWeill Medical College of Cornell University2402026-02-022026-10-16
Heart Rate Control Before Cardiac Computed Tomography in Adults for the Evaluation of Coronary Artery Disease
atenolol, Metoprolol tartrate, Ivabradine - Coronary Arterial Disease (CAD), Ischemic Heart Disease (IHD)
Phase 2 / Phase 3Enrolling by invitationGødstrup Hospital3502025-12-152025-12-17
Effect of Beta-blockers on Coronary Flow and Resistance in Patients With ANOCA
Saline (NaCl), Metoprolol Tartrate - Coronary Arterial Disease (CAD), Angina (Stable)
Phase 4RecruitingVZW Cardiovascular Research Center Aalst462025-07-032025-07-14
Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis
Caffeine, Metoprolol, Midazolam - Atopic Dermatitis
Early Phase 1CompletedAmgen212023-06-032025-12-23
Impact of Beta-blockers on Physical Function in HFpEF
Beta blockers - Heart Failure, Heart Failure, Diastolic
Phase 4CompletedWeill Medical College of Cornell University92021-04-012023-09-08
Pilot Deprescribing N-of-1 Trials for Beta-blockers in HFpEF
Beta blockers - Heart Failure, Heart Failure, Diastolic
Phase 4CompletedWeill Medical College of Cornell University92021-04-012024-04-09
Heart Rate Controller in Computed Tomography Coronary Angiography
Metoprolol tartrate, Ivabradine, Diltiazem - Heart Rate, Coronary Computed Tomography Angiography
Phase 4UnknownMahidol University2462021-01-302022-05-17
Study in Healthy Subjects to Determine the Effect of Relacorilant on Exposure to Probe Substrates for Cytochrome P450s
Midazolam hydrochloride, Metoprolol tartrate, Pioglitazone hydrochloride - Healthy
Phase 1CompletedCorcept Therapeutics272018-03-062018-05-17
Evaluation of Bromocriptine, Metoprolol and Tamsulosin in Eyes With Non-Central DME
Bromocriptine 2.5 MG, Metoprolol 25 MG, Tamsulosin 0.4 MG - Diabetic Macular Edema
Phase 1 / Phase 2WithdrawnAndrew Moshfeghi, MD, MBA2018-03-012019-04-01
Metoprolol to Reduce Perioperative Myocardial Injury
Metoprolol Tartrate, Placebo - Heart Diseases
Phase 3CompletedUniversity of Chicago722016-12-012026-01-28
Rate Control in Atrial Fibrillation
Carvedilol, Metoprolol tartrate - Atrial Fibrillation
Phase 4UnknownCreighton University202016-12-012016-06-16
Effects of Lipid Emulsion on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol.
metoprolol, intravenous lipid emulsion, Sodium chloride 0.9% solution - lipid emulsion dummy - Drug Overdose, Overdose of Beta-adrenergic Blocking Drug
Phase 4CompletedMikkel Bring Christensen102016-09-012017-04-12
Efficacy and Safety of Metoprolol Tartrate Tablets Combined With Chinese Traditional Medicine on Premature Ventricular Complex.
Tongmai Yangxin Pill (TMYXP), metoprolol tartrate, placebo - Premature Ventricular Contraction
Phase 4CompletedXuanwu Hospital, Beijing5842014-01-012021-08-17
Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED)
Low-dose rtPA, Standard-dose rtPA, Intensive blood pressure (BP) lowering - Ischemic Stroke, High Blood Pressure
Phase 3CompletedThe George Institute45872012-03-012021-10-13
The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial
Blood pressure management policies - Intracerebral Hemorrhage, Stroke
Not applicableCompletedThe George Institute28392008-09-012013-12-13
Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage
Labetalol Hydrochloride, Metoprolol tartrate, Hydralazine Hydrochloride - CVA (Cerebrovascular Accident), Cerebral Hemorrhage
Not applicableCompletedThe George Institute4042005-11-012008-06-26
Black Education and Treatment of Hypertension (BEAT HTN)
Hydrochlorothiazide, Lisinopril, Lisinopril and Hydrochlorothiazide - Hypertension
Phase 4CompletedCreighton University992005-08-012012-12-04
Treatment of Supine Hypertension in Autonomic Failure
Clonidine, Nitroglycerin transdermal, Dipyridamole/ Aspirin (Aggrenox) - Hypertension
Phase 1CompletedVanderbilt University1522001-01-012017-10-13

Conditions studied

Hypertension (4)  ·  Heart Diseases (3)  ·  Heart Failure (3)  ·  Atrial Fibrillation (2)  ·  Cerebral Hemorrhage (2)  ·  Coronary Artery Disease (2)  ·  Heart Failure, Diastolic (2)  ·  Stroke (2)  ·  Angina Pectoris (1)  ·  Angina, Stable (1)  ·  Dermatitis, Atopic (1)  ·  Drug Overdose (1)  ·  Intracranial Hemorrhages (1)  ·  Ischemic Stroke (1)  ·  Multiple System Atrophy (1)

Sponsors

The George Institute (3)  ·  Weill Medical College of Cornell University (3)  ·  Creighton University (2)  ·  Amgen (1)  ·  Andrew Moshfeghi, MD, MBA (1)  ·  Corcept Therapeutics (1)  ·  Gødstrup Hospital (1)  ·  Mahidol University (1)  ·  Mikkel Bring Christensen (1)  ·  Muhammad Ali Javed (1)  ·  University of Chicago (1)  ·  VZW Cardiovascular Research Center Aalst (1)  ·  Vanderbilt University (1)  ·  Xuanwu Hospital, Beijing (1)

Countries

United States (10)  ·  Australia (3)  ·  Belgium (2)  ·  China (2)  ·  Denmark (2)  ·  Argentina (1)  ·  Austria (1)  ·  Brazil (1)  ·  Chile (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  India (1)  ·  Italy (1)

Top investigators

Craig Anderson, PhD (2)  ·  Parag Goyal, MD (2)  ·  Andrew A. Moshfeghi, MD, MBA (1)  ·  Andrew Ambrosy, MD, MPH (1)  ·  Bruce Neal, PhD (1)  ·  Craig S Anderson, MD (1)  ·  Italo Biaggioni, MD (1)  ·  Kirsteen Donaldson, FFPM,DM,FRCP (1)  ·  Mikkel B Christensen, MD, PhD (1)  ·  Pallavi Bellamkonda, MBBS (1)  ·  Parag Goyal, MD, MSc (1)  ·  Peter Nagele, MD (1)  ·  Prichapol Thantassanee, M.D. (1)

Results publications

PMID 32640944, PMID 25503550, PMID 25589782, PMID 25657175, PMID 25712944, PMID 25823544, PMID 26746184, PMID 27165954, PMID 27178897, PMID 27919055, PMID 30890109, PMID 31085948, PMID 33598552, PMID 38018833, PMID 40541207, PMID 41855454, PMID 42848972, PMID 10851208, PMID 11927799, PMID 12119802, PMID 12923400, PMID 15738343, PMID 16391172, PMID 16533484, PMID 18396107, PMID 18426998, PMID 19047577, PMID 19738158, PMID 20823381, PMID 22129475, PMID 22678090, PMID 22744655, PMID 22801444, PMID 23266540, PMID 23713578, PMID 24149007, PMID 24530176, PMID 25497513, PMID 25677598, PMID 25801872, PMID 26044442, PMID 26202097, PMID 26265125, PMID 26810526, PMID 26814235, PMID 26846860, PMID 26859491, PMID 27009893, PMID 27073236, PMID 27143274

NIH funding

2025 (1), K76AG064428 (1), R01AG091005 (1), R01HL126892 (1)